[1] [1] ZHANG X X, KONG J, YUN K, et al. Prevalence of diabetic nephropathy among patients with type 2 diabetes mellitus in China:a meta-analysis of observational studies［J］. Journal of DiabetesResearch, 2020, 2020: 2315607.

[2] [2] HE Fangfang, SONG Cangsang, ZHANG Yang, et al. Rapidhealth technology assessment of metformin plus dapagliflozin intreatment of type 2 diabetes mellitus［J］. Chinese Journal of DrugEvaluation, 2022, 39(3): 248-253.

[3] [3] GU L Y, SUN Y, TANG H T, et al. Huangkui capsule in combination with metformin ameliorates diabetic nephropathy via theKlotho/TGF-β1/p38MAPK signaling pathway［J］. Journal of Ethnopharmacology, 2021, 281: 113548.

[4] [4] KUNNUMAKKARA A B, SHABNAM B, GIRISA S, et al. Inflammation, NF-κB, and chronic diseases: how are they linked？［J］.Critical Reviews in Immunology, 2020, 40(1): 1-39.

[5] [5] KO K I, SYVERSON A L, KRALIK R M, et al. Diabetes-inducedNF-κB dysregulation in skeletal stem cells prevents resolution ofinflammation［J］. Diabetes, 2019, 68(11): 2095-2106.

[6] [6] SUN H J, XIONG S P, CAO X, et al. Polysulfide-mediated sulfhydration of SIRT1 prevents diabetic nephropathy by suppressingphosphorylation and acetylation of p65 NF-κB and STAT3［J］.Redox Biology, 2021, 38: 101813.

[7] [7] DUAN Yanfang, LIU Fengwei, QIN Yeqiang, et al. The effect ofmetformin on typeⅡ alveolar epithelial cell EMT in gestationaldiabetic mellitus rats based on NF-κB/twist 1 pathway［J］. Medical Journal of West China, 2022, 34(10): 1432-1436, 1441.

[8] [8] WU Xiaomei, SHI Caifeng, ZHOU Yang, et al. Relationship betweenquality of life and diabetic nephropathy in patients with type 2 diabetes mellitus［J］. Shandong Medical Journal, 2022, 62(27): 77-79.

[9] [9] LU Qiqi, YU Chao, WANG Zhiping, et al. Research progress ofdiabetic nephropathy induced by p38MAPK signaling pathway［J］.Chinese Journal of Gerontology, 2022, 42(8): 2011-2016.

[10] [10] HU Wei, XIONG Dan, HUANG Juan, et al. Mechanism of BushenHuoxue decoction in inhibiting podocyte injury and EMT inducedby diabetic nephropathy［J］. Journal of Tianjin University of Traditional Chinese Medicine, 2019, 38(3): 262-266.

[11] [11] WANG Wenting, HU Yangzhi, ZHANG Qian, et al. The relationship between metformin and the proliferation, migration and epithelial-mesenchymal transition in gastric cancer cells［J］. MedicalJournal of West China, 2022, 34(4): 516-519, 524.

[12] [12] ZHENG Chen, ZHU Jun, HE Xianfeng, et al. Effects of ShenqiJiangtang Granules combined with pioglitazone and metformin ondiabetic patients with metabolic syndrome［J］. World of Traditional Chinese Medicine, 2022, 17(2): 237-242.

[13] [13] WANG M, WENG X D, GUO J, et al. Metformin alleviated EMTand fibrosis after renal ischemia-reperfusion injury in rats［J］. Renal Failure, 2016, 38(4): 614-621.

[14] [14] BRABLETZ S, SCHUHWERK H, BRABLETZ T, et al. DynamicEMT: a multi-tool for tumor progression［J］. EMBO Journal,2021, 40(18): e108647.

[15] [15] XU Qingdong, GUO Huankai, SU Ming, et al. Expression ofPPARγ and PTEN in diabetic renal tissues and their effects onEMT and fibrosis［J］. Central South Journal of Medical Sciences,2020, 48(5): 499-504.

[16] [16] TU Q D, LI Y W, JIN J, et al. Curcumin alleviates diabetic nephropathy via inhibiting podocyte mesenchymal transdifferentiation and inducing autophagy in rats and MPC5 cells［J］. Pharmaceutical Biology, 2019, 57(1): 778-786.

[17] [17] XUE Guoqiang, WEI Xinxin, YAO Na, et al. Metformin protectstype 2 diabetic kidneys by regulating PARP-1 activity［J］. Journalof Kunming Medical University, 2021, 42(6): 29-37.

[18] [18] ZUSSO M, LUNARDI V, FRANCESCHINI D, et al. Ciprofloxacin and levofloxacin attenuate microglia inflammatory responsevia TLR4/NF-κB pathway［J］. Journal of Neuroinflammation,2019, 16(1): 148.

[19] [19] XING Lina, TIAN Tian, WANG Ying, et al. Effects of miR-335on Survivin and NF-κB expressions on invasion, migration andapoptosis of B-cell lymphoma cells［J］. Chinese Journal of Immunology, 2022, 38(13): 1597-1600.

[20] [20] ZHAO Y, SUN M J. Metformin rescues parkin protein expressionand mitophagy in high glucose-challenged human renal epithelialcells by inhibiting NF-κB via PP2A activation［J］. Life Sciences,2020, 246: 117382.